TALIS BIOMEDICAL CORP - COM (TLIS)

CUSIP: 87424L108

Q4 2022 13F Holders as of 31 Dec 2022

Type / Class
Equity / COM
Total 13F shares
12,577,892
Share change
-25,156
Total reported value
$5,604,200
Price per share
$0.45
Number of holders
24
Value change
-$30,748
Number of buys
12
Number of sells
9

Quarterly Holders Quick Answers

What is CUSIP 87424L108?
CUSIP 87424L108 identifies TLIS - TALIS BIOMEDICAL CORP - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of TALIS BIOMEDICAL CORP - COM (TLIS) as of Q4 2022

As of 31 Dec 2022, TALIS BIOMEDICAL CORP - COM (TLIS) was held by 24 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 12,577,892 shares. The largest 10 holders included BAKER BROS. ADVISORS LP, GREENLIGHT CAPITAL INC, ArrowMark Colorado Holdings LLC, VANGUARD GROUP INC, PRELUDE CAPITAL MANAGEMENT, LLC, GEODE CAPITAL MANAGEMENT, LLC, MILLENNIUM MANAGEMENT LLC, BlackRock Inc., CITADEL ADVISORS LLC, and MERCER GLOBAL ADVISORS INC /ADV. This page lists 24 institutional shareholders reporting positions in this security for the Q4 2022 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.